Gene content    
PML ( by HUGO)
Promyelocytic Leukemia
Tumor suppressor gene
Promyelocytic Leukemia
MYL
Promyelocytic Leukemia Protein
Tripartite Motif-Containing Protein 19
PP8675
RNF71
TRIM19
RING Finger Protein 71
Probable Transcription Factor PML
Promyelocytic Leukemia
Inducer Of
Protein PML
Tripartite Motif Protein TRIM19
NCBI: 15q22    Ensembl: 15q24.1
PML_HUMANSize: 882 amino acidsMass: 97551 Da

  • Subunit: Key component of PML bodies. PML bodies are formed by the interaction of PML homodimers (via SUMO-binding motif) with sumoylated PML, leading to the assembly of higher oligomers. Several types of PML bodies have been observed. PML bodies can form hollow spheres that can sequester target proteins inside. Interacts (via SUMO-binding motif) with sumoylated proteins. Interacts (via C-terminus) with p53/TP53. Recruits p53/TP53 and CHEK2 into PML bodies, which promotes p53/TP53 phosphorylation at 'Ser-20' and prevents its proteasomal degradation. Interacts with MDM2, and sequesters MDM2 in the nucleolus, thereby preventing ubiquitination of p53/TP53. Interaction with PML-RARA oncoprotein and certain viral proteins causes disassembly of PML bodies and abolishes the normal PML function. Interacts with HIPK2, TERT, SIRT1, TOPBP1, TRIM27 and TRIM69. Interacts with ELF4 (via C-terminus). Interacts with Lassa virus Z protein and rabies virus phosphoprotein. Interacts with ITPR3. Interacts (in the cytoplasm) with TGFBR1, TGFBR2 and PKM. Interacts (via the coiled-coil domain and when sumoylated) with SATB1. Interacts with UBE2I; the interaction is enhanced by arsenic binding. Interacts (PML-RARA oncoprotein, via the coiled-coil domain) with UBE2I; the interaction is enhanced by arsenic binding and is required for PML-RARA oncoprotein sumoylation and inhibition of RARA transactivational activity. Interacts with RB1, PPP1A, SMAD2, SMAD3, DAXX, RPL11 and MTOR. Interacts with PPARGC1A and KAT2A. Interacts with CSNK2A1 and CSNK2A3. Interacts with ANKRD2; the interaction is direct. Isoform PML-1, isoform PML-2, isoform PML-3, isoform PML-4, isoform PML-5 and isoform PML-6 interact with RNF4. Isoform PML-1 interacts with NLRP3. Isoform PML-1, isoform PML-2, isoform PML-3, isoform PML-4 and isoform PML-5 interact with MAGEA2, RBL2, PER2 and E2F4. Isoform PML-2 interacts with CIITA. Isoform PML-2, isoform PML-3 and isoform PML-4 interact with TBX2. Isoform PML-4 interacts with RANBP2, HDAC7, KAT6A, WRN, PIN1, TBX3 and phosphorylated MAPK1/ERK2. Isoform PML-4 interacts with the CTNNB1 and TCF7L2/TCF4 complex. Isoform PML-4 preferentially interacts with MAPK7/BMK1 although other isoforms (isoform PML-1, isoform PML-2, isoform PML-3 and isoform PML-6) also interact with it. Isoform PML-12 interacts with PIAS1, PIAS2 (isoform PIAS2-alpha) and CSNK2A1/CK2. Isoform PML-3 interacts with HFV bel1/tas and bet. Isoform PML-4 interacts with VZV capsid protein VP26/ORF23 capsid protein. Ths sumoylated isoform PML-4 interacts with encephalomyocarditis virus (EMCV) RNA-directed RNA polymerase 3D-POL (P3D-POL). Isoform PML-1 interacts with herpes simplex virus-1 (HHV-1) ICP0. Isoform PML-2 interacts with human adenovirus 2 E1A and this interaction stimulates E1A-dependent transcriptional activation. Isoform PML-6 interacts with moloney murine leukemia virus (MoMLV) integrase (IN) and reverse transcriptase (RT) Sequence caution: Sequence=AAA60351.1; Type=Erroneous initiation; Note=Translation N-terminally extended; Sequence=AAA60352.1; Type=Erroneous initiation; Note=Translation N-terminally extended; Sequence=AAA60388.1; Type=Erroneous initiation; Note=Translation N-terminally extended; Sequence=AAA60390.1; Type=Erroneous initiation; Note=Translation N-terminally extended; Sequence=BAB62809.1; Type=Miscellaneous discrepancy; Note=Chimeric cDNA; Sequence=BAD92648.1; Type=Erroneous initiation; Note=Translation N-terminally shortened; 1 PDB 3D structure from [IMAGE] and Proteopedia [IMAGE] for PML: 1BOR (3D) [IMAGE]
  • Function:
    UniProtKB/Swiss-Prot Summary: PML_HUMAN, P29590 Function: Functions via its association with PML-nuclear bodies (PML-NBs) in a wide range of important cellular processes, including tumor suppression, transcriptional regulation, apoptosis, senescence, DNA damage response, and viral defense mechanisms. Acts as the scaffold of PML-NBs allowing other proteins to shuttle in and out, a process which is regulated by SUMO-mediated modifications and interactions. Isoform PML-4 has a multifaceted role in the regulation of apoptosis and growth suppression: activates RB1 and inhibits AKT1 via interactions with PP1 and PP2A phosphatases respectively, negatively affects the PI3K pathway by inhibiting MTOR and activating PTEN, and positively regulates p53/TP53 by acting at different levels (by promoting its acetylation and phosphorylation and by inhibiting its MDM2-dependent degradation). Isoform PML-4 also: acts as a transcriptional repressor of TBX2 during cellular senescence and the repression is dependent on a functional RBL2/E2F4 repressor complex, regulates double-strand break repair in gamma-irradiation-induced DNA damage responses via its interaction with WRN, acts as a negative regulator of telomerase by interacting with TERT, and regulates PER2 nuclear localization and circadian function. Isoform PML-6 inhibits specifically the activity of the tetrameric form of PKM. The nuclear isoforms (isoform PML-1, isoform PML-2, isoform PML-3, isoform PML-4 and isoform PML-5) in concert with SATB1 are involved in local chromatin-loop remodeling and gene expression regulation at the MHC-I locus. Isoform PML-2 is required for efficient IFN-gamma induced MHC II gene transcription via regulation of CIITA. Cytoplasmic PML is involved in the regulation of the TGF-beta signaling pathway. PML also regulates transcription activity of ELF4 and can act as an important mediator for TNF-alpha- and IFN-alpha-mediated inhibition of endothelial cell network formation and migration Function: Exhibits antiviral activity against both DNA and RNA viruses. The antiviral activity can involve one or several isoform(s) and can be enhanced by the permanent PML-NB-associated protein DAXX or by the recruitment of p53/TP53 within these structures. Isoform PML-4 restricts varicella zoster virus (VZV) via sequestration of virion capsids in PML-NBs thereby preventing their nuclear egress and inhibiting formation of infectious virus particles. The sumoylated isoform PML-4 restricts rabies virus by inhibiting viral mRNA and protein synthesis. The cytoplasmic isoform PML-14 can restrict herpes simplex virus-1 (HHV-1) replication by sequestering the viral E3 ubiquitin-protein ligase ICP0 in the cytoplasm. Isoform PML-6 shows restriction activity towards human cytomegalovirus (HCMV) and influenza A virus strains PR8(H1N1) and ST364(H3N2). Sumoylated isoform PML-4 and isoform PML-12 show antiviral activity against encephalomyocarditis virus (EMCV) by promoting nuclear sequestration of viral polymerase (P3D-POL) within PML NBs. Isoform PML-3 exhibits antiviral activity against poliovirus by inducing apoptosis in infected cells through the recruitment and the activation of p53/TP53 in the PML-NBs. Isoform PML-3 represses human foamy virus (HFV) transcription by complexing the HFV transactivator, bel1/tas, preventing its binding to viral DNA. PML may positively regulate infectious hepatitis C viral (HCV) production and isoform PML-2 may enhance adenovirus transcription
  • Similarity:
    Contains 2 B box-type zinc fingers
                          
    Contains 1 RING-type zinc finger [IMAGE]
  • Protein Domain/Family    
    Source ID Domain Name Type
    InterProIPR000315Znf_B-boxZinc finger, B-boxDomain
    IPR001841Znf_RINGZinc finger, RING-typeDomain
    BlocksIPB000315B-box zinc finger signatureB-box zinc finger signature

    Gene Ontology    
    Type Term Evidence Source Pub
    Biological Process apoptotic process IDA GOA 9583681
    cell cycle arrest IDA GOA 12773567
    innate immune response IDA GOA 18248090
    intrinsic apoptotic signaling pathway in response to DNA damage IDA GOA 12402044
    maintenance of protein location in nucleus IDA GOA 17332504
    negative regulation of angiogenesis IMP GOA 16915281
    negative regulation of cell growth IDA GOA 7935403
    negative regulation of cell proliferation IMP GOA 12006491
    negative regulation of mitotic cell cycle IDA GOA 9395203
    negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process IMP GOA 15195100
    negative regulation of telomerase activity IMP GOA 19567472
    negative regulation of telomere maintenance via telomerase IMP GOA 19567472
    negative regulation of transcription, DNA-templated IDA GOA 11259576
    negative regulation of translation in response to oxidative stress IDA GOA 16915281
    PML body organization IDA GOA 10779416
    PML body organization IMP GOA 17081985
    positive regulation of apoptotic process involved in mammary gland involution IDA GOA 11080164
    positive regulation of defense response to virus by host IMP GOA 16873256
    positive regulation of histone deacetylation IDA GOA 11259576
    protein complex assembly IDA GOA 12915590
    protein stabilization IDA GOA 12773567
    protein targeting IMP GOA 15195100
    protein targeting IDA GOA 11080164
    response to cytokine IDA GOA 9412458
    response to hypoxia IDA GOA 16915281
    Cellular Component colocalizes_with PML body IDA GOA 10910364
    cytoplasm IDA GOA 16778193
    nuclear matrix IDA GOA 11080164
    nuclear membrane IDA GOA 123456
    nucleolus IDA GOA 15195100
    nucleoplasm IDA GOA 12915590
    PML body IDA GOA 11331580
    PML body TAS GOA 9230084
    Molecular Function cobalt ion binding IDA GOA 7729428
    protein binding IPI GOA 10597310
    protein heterodimerization activity IDA GOA 7935403
    protein homodimerization activity IPI GOA 9230084
    SUMO binding IPI GOA 17081985
    transcription coactivator activity IDA GOA 11080164
    ubiquitin protein ligase binding IPI GOA 12915590
    zinc ion binding IDA GOA 7729428

    Disorder & Mutation    
    Source Disease
    Genatlasacute promyelocytic leukemia (APL) with translocation t(15;17)(q22;q12) and with poor prognosis,may be associated with a hemorrhagic diathesis,secundary to an overexpression of annexin II with a secundary itinease of plasmin (see RARA)
    SWISS-PROTNote=A chromosomal aberration involving PML may be a cause of acute promyelocytic leukemia (APL). Translocation t(15;17)(q21;q21) with RARA. The PML breakpoints (type A and type B) lie on either side of an alternatively spliced exon

    PML cross reference    
    PubMed OMIM Entrez Gene NCKU SNP Nucleotide UniProt Genome Data Viewer HomoloGene